How will Biosecure Act impact Indian pharma companies? Aditya Khemka explains
“There should be an alternate vendor that can support you, even if at higher prices or higher cost. So, I think that is where the Indian players come in. Remember, last we checked, Indian API exports were around $4 billion and that number compares to China’s API exports of roughly $40 billion,” says Aditya Khemka, … Read more